Key facts
- This page summarizes Jesse Shefferman's Form 4 filing for Protara Therapeutics, Inc. (TARA).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 27 Jun 2023, 19:26.
Jesse Shefferman - 23 Jun 2023 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)
- Reporting relationship
- CEO and President, Director
- Issuer ticker
- TARA
- Reported as of
- 23 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 Jun 2023, 19:26:20 UTC
- Prior SEC filing
- 20 Jan 2023
- Next SEC filing
- 05 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jesse Shefferman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jesse Shefferman filed Form 4 for Protara Therapeutics, Inc. (TARA) on 27 Jun 2023.
Change
- Previous filing in this sequence was filed on 20 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TARA
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -1,890
- Change %
- -0.21%
- Price
- $0.000000
- Shares after
- 911,873
- Date
- 23 Jun 2023
- Ownership
- Direct
TARA
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -7,420
- Change %
- -0.81%
- Price
- $0.000000
- Shares after
- 904,453
- Date
- 27 Jun 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.